ISIN | CH0111012412 |
---|---|
Valor Number | 11101241 |
Bloomberg Global ID | BBG000QM5HR0 |
Fund Name | LO Funds (CH) - Swiss Equity Factor Enhanced I D |
Fund Provider |
Lombard Odier Asset Management (Switzerland) SA
Genève, Switzerland Phone: +41 22 709 21 11 E-Mail: contact@lombardodier.com Web: www.lombardodier.com |
Fund Provider | Lombard Odier Asset Management (Switzerland) SA |
Representative in Switzerland | |
Distributor(s) |
Lombard Odier Funds (Switzerland) S.A Petit-Lancy Phone: +41 22 709 21 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Fund is to track the SMI as exactly as possible while minimizing transaction costs. This is achieved by investing directly in every single underlying security contained in the reference index and in the same proportion (Full index replication methodology). |
Peculiarities |
Current Price * | 201.23 CHF | 01.11.2024 |
---|---|---|
Previous Price * | 198.50 CHF | 31.10.2024 |
52 Week High * | 208.52 CHF | 02.09.2024 |
52 Week Low * | 175.72 CHF | 10.11.2023 |
NAV * | 201.23 CHF | 01.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 69,019,987 | |
Unit/Share Assets *** | 6,953,101 | |
Trading Information SIX |
YTD Performance | +9.18% |
29.12.2023 - 01.11.2024
29.12.2023 01.11.2024 |
---|---|---|
1 month | -1.21% |
01.10.2024 - 01.11.2024
01.10.2024 01.11.2024 |
3 months | +0.82% |
02.08.2024 - 01.11.2024
02.08.2024 01.11.2024 |
6 months | +5.83% |
01.05.2024 - 01.11.2024
01.05.2024 01.11.2024 |
1 year | +12.38% |
01.11.2023 - 01.11.2024
01.11.2023 01.11.2024 |
2 years | +9.24% |
01.11.2022 - 01.11.2024
01.11.2022 01.11.2024 |
3 years | -6.16% |
01.11.2021 - 01.11.2024
01.11.2021 01.11.2024 |
5 years | +22.35% |
01.11.2019 - 01.11.2024
01.11.2019 01.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 14.40% | |
---|---|---|
Novartis AG Registered Shares | 13.10% | |
Roche Holding AG | 12.67% | |
UBS Group AG | 4.95% | |
Compagnie Financiere Richemont SA Class A | 4.74% | |
ABB Ltd | 4.49% | |
Zurich Insurance Group AG | 4.32% | |
Sika AG | 2.92% | |
Alcon Inc | 2.41% | |
Holcim Ltd | 2.38% | |
Last data update | 31.08.2024 |
TER | 0.73% |
---|---|
TER date | 31.01.2020 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.40% |
Ongoing Charges *** | 0.33% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |